Jillian B. Thomsen, Chief Financial Officer at NEKTAR THERAPEUTICS (NKTR), sold 10,267 shares at $3.00 ($31K) on 2023-02-16, disclosed to the SEC on 2023-02-17.
Seasonal sale ($31k) by Chief Financial Officer — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |
| NKTR | SELL | 2021-11-17 | $177K | — | Filing → |